7575-93-1 Usage
Description
Methyl-D3 p-toluenesulfonate, also known as Methyl-D3 4-methylbenzenesulfonate or Methyl-D3 tosylate, is a specialized deuterated chemical compound used in organic synthesis and pharmaceutical research. It contains deuterium (D), a heavy hydrogen isotope, and has a molecular formula of C8H5D3O3S, with three deuterium atoms (D3) in its structure. METHYL-D3 P-TOLUENESULFONATE is valued for its ability to create compounds with enhanced properties, such as improved stability or metabolic tracking capabilities in pharmaceuticals. Due to potential safety hazards, it is crucial to handle Methyl-D3 p-toluenesulfonate with care.
Uses
Used in Organic Synthesis:
Methyl-D3 p-toluenesulfonate is used as a reagent in organic synthesis for creating compounds with improved properties. Its deuterated nature allows for the synthesis of molecules with increased stability, which can be beneficial in various chemical applications.
Used in Pharmaceutical Research:
In pharmaceutical research, Methyl-D3 p-toluenesulfonate is used as a tool for metabolic tracking. The presence of deuterium atoms in its structure enables researchers to monitor the metabolism of compounds in biological systems, providing valuable insights into drug development and optimization.
Used in Chemical Analysis:
Methyl-D3 p-toluenesulfonate is employed as an internal standard in chemical analysis, particularly in mass spectrometry. The incorporation of deuterium atoms allows for accurate quantification and identification of target compounds, enhancing the reliability of analytical results.
Check Digit Verification of cas no
The CAS Registry Mumber 7575-93-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,5,7 and 5 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 7575-93:
(6*7)+(5*5)+(4*7)+(3*5)+(2*9)+(1*3)=131
131 % 10 = 1
So 7575-93-1 is a valid CAS Registry Number.
7575-93-1Relevant articles and documents
Deuterated compound and application thereof in treatment of cancer
-
Paragraph 0129-0130, (2021/03/06)
The present invention relates to a deuterated compound and application thereof in the treatment of cancer. Specifically, the present invention provides the compound of formula (I) and pharmaceuticallyacceptable salt or ester thereof, and a pharmaceutical composition thereof. The compound and the pharmaceutical composition are used for inhibiting or regulating the activity of tyrosine kinase and treating disease symptoms or symptoms including cancer mediated by tyrosine kinase.
Deuterated substituted butenamide and preparation method and application thereof
-
Paragraph 0175-0177, (2021/10/13)
The invention belongs to the field of medicines, and particularly relates to deuterated substituted butenamide and a preparation method and application thereof. The deuterated substituted butenamide is prepared from the intermediate compound shown V. Compared with the prior art, the deuterated substituted butenamide is used. The deuterated substituted butane acetamide - N - oxide has a good anti-cancer effect, and the application prospect of the medicine is increased for anti-cancer treatment drugs. , The deuterated substituted butanamide and the deuterated substituted butane acetamide - N - oxide are prepared by the process, the operation is simple, the purity is high, the three wastes are few, and the process is environment-friendly and friendly.
Construction of Biaryls from Aryl Sulfoxides and Anilines by Means of a Sigmatropic Rearrangement
Yanagi, Tomoyuki,Nogi, Keisuke,Yorimitsu, Hideki
, p. 783 - 787 (2019/11/13)
An unprecedented S?N variant of the benzidine rearrangement for construction of biaryls has been developed. Aryl sulfoxides underwent dehydrogenative coupling with anilines by successive treatment with trifluoromethanesulfonic anhydride and trifluorometha
